CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,312,000 | -40.1% | 290,000 | 0.0% | 0.02% | -40.7% |
| Q1 2019 | $7,198,000 | +38.2% | 290,000 | 0.0% | 0.03% | +22.7% |
| Q4 2018 | $5,208,000 | -38.9% | 290,000 | 0.0% | 0.02% | -29.0% |
| Q3 2018 | $8,518,000 | -30.6% | 290,000 | +7.4% | 0.03% | -32.6% |
| Q2 2018 | $12,277,000 | -10.6% | 270,000 | +3.8% | 0.05% | -13.2% |
| Q1 2018 | $13,728,000 | +404.7% | 260,000 | +550.0% | 0.05% | +430.0% |
| Q4 2017 | $2,720,000 | +120.1% | 40,000 | +166.7% | 0.01% | +100.0% |
| Q3 2017 | $1,236,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |